HomeInsightsStock Comparison

Sanofi Consumer Healthcare India Ltd vs Sequent Scientific Ltd Stock Comparison

Sanofi Consumer Healthcare India Ltd vs Sequent Scientific Ltd Stock Comparison

Last Updated on: Jun 04, 2025

Key Highlights

  • The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 5270 as of 04 Jun 15:30.
  • The P/E Ratio of Sanofi Consumer Healthcare India Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Sequent Scientific Ltd changed from 27.6 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Sequent Scientific Ltd changed from ₹ 1929 crore on March 2020 to ₹ 2875 crore on March 2024 . This represents a CAGR of 8.31% over 5 years.
  • The revenue of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sequent Scientific Ltd for the Mar '25 is ₹ 403.36 crore as compare to the Dec '24 revenue of ₹ 396.65 crore. This represent the growth of 1.69%.
  • The ebitda of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sequent Scientific Ltd for the Mar '25 is ₹ 47.56 crore as compare to the Dec '24 ebitda of ₹ 40.03 crore. This represent the growth of 18.81%.
  • The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Sequent Scientific Ltd changed from ₹ -34.68 crore to ₹ 10.38 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 0 % on March 2020 to 0 % on December 2024 . This represents a CAGR of 0.0% over 7 yearsThe Dividend Payout of Sequent Scientific Ltd changed from 38.67 % on March 2021 to 0 % on December 2024 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sanofi Consumer Healthcare India Ltd

  • Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, pursuant to a Certificate of Incorporation, issued by the Registrar of Companies, Central Registration Centre.
  • Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.
  • In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger.

About Sequent Scientific Ltd

  • Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself.
  • The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.

Sanofi Consumer Healthcare India Ltd News Hub

News

Sanofi Consumer reports 20% YoY fall in Q1 PAT to Rs 50 cr

Revenue from operations fell 22.11% YoY to Rs 172.60 crore in the quarter ended 31 March 2...

Read more

03 May 2025 15:12

News

Sanofi Consumer Healthcare India to convene board meeting

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Comp...

Read more

26 Apr 2025 10:37

News

Sanofi Consumer Healthcare CFO Maithilee Mistry resigns

According to an exchange filing, Mistry has decided to resign to explore new opportunities...

Read more

07 Apr 2025 12:44

News

Sanofi Consumer Healthcare India AGM scheduled

Sanofi Consumer Healthcare India announced that the 2nd Annual General Meeting(AGM) of the...

Read more

26 Mar 2025 17:41

News

Board of Sanofi Consumer Healthcare India recommends final dividend

Sanofi Consumer Healthcare India announced that the Board of Directors of the Company at i...

Read more

21 Feb 2025 09:40

News

Sanofi Consumer posts PAT of Rs 46 crore in Q3

Total operating expenditure rose by 13.8% YoY to Rs 111.50 crore in Q3 FY25, due to higher...

Read more

21 Feb 2025 10:34

Sequent Scientific Ltd News Hub

News

Sequent Scientific does not recommend dividend

The Board of Sequent Scientific at the meeting held on 20 May 2025, has decided not declar...

Read more

20 May 2025 15:40

News

Sequent Scientific to hold board meeting

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 20 May ...

Read more

08 May 2025 15:09

News

Sequent Scientific announces board meeting date

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 11 Febr...

Read more

05 Feb 2025 16:01

News

Sequent Scientific receives CCI approval for composite scheme of amalgamation

Sequent Scientific announced that the Competition Commission of India vide its letter date...

Read more

22 Jan 2025 13:56

News

Sequent Scientific allots 5.40 lakh equity shares under ESOP

Sequent Scientific has allotted 5,40,000 equity shares under ESOP on 23 November 2024. Wit...

Read more

25 Nov 2024 15:52

News

Sequent Scientific consolidates its holdings in N-VET AB, Sweden and Alivira Italia SRL, Italy

Sequent Scientific has completed the acquisition of 3.90% stake from Ms. Katarina Agren in...

Read more

22 Nov 2024 17:48

SWOT Analysis Of Sequent Scientific Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sanofi Consumer Healthcare India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sequent Scientific Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Sequent Scientific Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Sequent Scientific Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 12,138 Cr while Market cap of Sequent Scientific Ltd is 4,809 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Sequent Scientific Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Sequent Scientific Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Sequent Scientific Ltd?

As of June 4, 2025, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹5270.45. On the other hand, Sequent Scientific Ltd stock price is INR ₹192.15.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Sequent Scientific Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Sequent Scientific Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions